beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-alpha-D-GalpNAc

Term ID

CHEBI:146751

Synonyms

beta-D-galacto-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranosyl-(1->6)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose
beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->6)-2-acetamido-2-deoxy-alpha-D-galactopyranose
Gal(b1-4)Glc(b1-6)a-GalNAc
N-[(2S,3R,4R,5R,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-2,4,5-trihydroxyoxan-3-yl]acetamide

Definition

An amino trisaccharide consisting of β-lactose and 2-acetamido-2-deoxy-α-D-galactopyranose joined by a (1→6) glycosidic bond.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-alpha-D-GalpNAc

Phenotype where environments contain beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-alpha-D-GalpNAc

Phenotype modified by environments containing beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-alpha-D-GalpNAc

Phenotype affecting beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-alpha-D-GalpNAc

Human Disease Model